HUP0203285A3 - Pharmaceutical composition comprising an insulin sensitizer and its use - Google Patents

Pharmaceutical composition comprising an insulin sensitizer and its use

Info

Publication number
HUP0203285A3
HUP0203285A3 HU0203285A HUP0203285A HUP0203285A3 HU P0203285 A3 HUP0203285 A3 HU P0203285A3 HU 0203285 A HU0203285 A HU 0203285A HU P0203285 A HUP0203285 A HU P0203285A HU P0203285 A3 HUP0203285 A3 HU P0203285A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
insulin sensitizer
sensitizer
insulin
pharmaceutical
Prior art date
Application number
HU0203285A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of HUP0203285A2 publication Critical patent/HUP0203285A2/hu
Publication of HUP0203285A3 publication Critical patent/HUP0203285A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0203285A 1999-09-03 2000-09-01 Pharmaceutical composition comprising an insulin sensitizer and its use HUP0203285A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25044399 1999-09-03
JP2000056021 2000-02-28
PCT/JP2000/005951 WO2001017513A2 (en) 1999-09-03 2000-09-01 Pharmaceutical composition comprising an insulin sensitizer

Publications (2)

Publication Number Publication Date
HUP0203285A2 HUP0203285A2 (hu) 2003-01-28
HUP0203285A3 true HUP0203285A3 (en) 2003-02-28

Family

ID=26539777

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203285A HUP0203285A3 (en) 1999-09-03 2000-09-01 Pharmaceutical composition comprising an insulin sensitizer and its use

Country Status (14)

Country Link
EP (1) EP1212090A2 (pl)
KR (1) KR20020063555A (pl)
CN (1) CN1372476A (pl)
AR (1) AR031674A1 (pl)
AU (1) AU6868000A (pl)
CA (1) CA2383946A1 (pl)
CO (1) CO5180632A1 (pl)
HK (1) HK1044711A1 (pl)
HU (1) HUP0203285A3 (pl)
NO (1) NO20021036L (pl)
PE (1) PE20010580A1 (pl)
PL (1) PL354295A1 (pl)
RU (1) RU2002108346A (pl)
WO (1) WO2001017513A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE341343T1 (de) 2000-12-26 2006-10-15 Sankyo Co Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel
WO2002080936A1 (en) 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
JP4590158B2 (ja) 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド グルコース再吸収阻害剤およびレチノイド−x受容体モジュレーターを含んで成る併用療法
FR2838968A1 (fr) * 2002-04-30 2003-10-31 Lipha Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete
WO2003106418A1 (ja) * 2002-06-01 2003-12-24 住友製薬株式会社 インドール、インダゾール、およびベンズアゾール類

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04501722A (ja) * 1988-11-14 1992-03-26 ジ・アップジョン・カンパニー 抗―糖尿病、抗―肥満症および抗―アテローム性動脈硬化症薬として有用なα―アミノ―インドール―3―酢酸
DE69100282T3 (de) * 1990-02-09 2001-01-11 Pharmacia & Upjohn Co., Kalamazoo Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
NZ295749A (en) * 1994-11-29 1998-05-27 Dainippon Pharmaceutical Co Indole derivatives; preparation and medicaments for treating obesity and diabetes mellitus

Also Published As

Publication number Publication date
HUP0203285A2 (hu) 2003-01-28
CO5180632A1 (es) 2002-07-30
AU6868000A (en) 2001-04-10
RU2002108346A (ru) 2003-11-20
CN1372476A (zh) 2002-10-02
NO20021036D0 (no) 2002-03-01
CA2383946A1 (en) 2001-03-15
NO20021036L (no) 2002-04-26
KR20020063555A (ko) 2002-08-03
HK1044711A1 (zh) 2002-11-01
PE20010580A1 (es) 2001-05-25
AR031674A1 (es) 2003-10-01
PL354295A1 (pl) 2004-01-12
WO2001017513A3 (en) 2001-09-20
EP1212090A2 (en) 2002-06-12
WO2001017513A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
PT1286966E (pt) Derivados de 4-aminopiperidina e a sua utilização como um medicamento
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
IL149757A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
HUP0200155A3 (en) Thioamide derivatives, pharmaceutical compositions containing them and their use
PL351387A1 (en) Pharmaceutical composition
HUP0201818A3 (en) 3alpha-hydroxy-3beta-methoxymethyl-21-heterocycle substituted steroids with anesthetic activity and pharmaceutical compositions containing the same
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
PL342515A1 (en) Drug administering device
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
AU5326100A (en) Pharmaceutical compositions and methods for use
GB2356144B (en) Hypodermic syringe
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL137415A0 (en) Cyclobutene derivatives and pharmaceutical compositions containing the same
HUP0203121A3 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
IL152978A0 (en) Macromolecular drug complexes and compositions containing the same
HUP0003189A3 (en) Pharmaceutical composition comprising fexofenadine and its derivatives
HUP0203285A3 (en) Pharmaceutical composition comprising an insulin sensitizer and its use
IL144525A0 (en) Benzamide derivatives and drugs containing the same
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof